0K91.F Quantum BioPharma Ltd.

Healthcare Biotechnology Frankfurt Exchange
1.85 EUR
Close of Nov 11, 2026
1.61 10.70
Market cap
EUR 11.9M
P/E
-
P/B
2.11x
ROE
-423.0%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 0K91.F undervalued?

Graham number

The Graham number of Quantum BioPharma Ltd. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Quantum BioPharma Ltd. fundamental analysis

No fundamental analysis for Quantum BioPharma Ltd. yet.

Quantum BioPharma Ltd. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Quantum BioPharma Ltd.

Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. The company operates through two segments, Biopharmaceutical Innovation and Strategic Investments. It researches and develops a portfolio of assets and biotech solutions for the treatment of neurodegenerative, inflammatory and metabolic disorders, and alcohol misuse disorders with drug candidates in different stages of development. The company's lead compound is Lucid-MS, a paten…

Full company profile